Physician profile
Deepak Pasi
NPI 1215936398
$3,889.58
in general payments reported to CMS, 2019-2025
27 companies · $829 in 2025
The $829 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $187 · 2021: $346 · 2022: $701 · 2023: $262 · 2024: $1,254 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,344.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $619.11 | 2020-2025 | Watchman Flx, General - Therapies, Watchman Access System |
| Abiomed | $443.90 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $440.01 | 2022-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $320.62 | 2019-2025 | Farxiga |
| Novartis Pharmaceuticals Corporation | $314.96 | 2019-2025 | |
| Esperion Therapeutics, INC. | $219.79 | 2021-2025 | Nexletol |
| Medtronic, INC. | $191.61 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $172.95 | 2024-2025 | Jardiance |
| Amgen INC. | $172.01 | 2024-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $168.97 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $155.09 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $101.65 | 2019-2023 | Lifevest |
| Irhythm Technologies, INC. | $98.34 | 2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $85.79 | 2025 | Wegovy, Ozempic |
| Celgene Corporation | $82.08 | 2022-2024 | Camzyos |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $67.01 | 2023-2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $61.93 | 2023-2024 | Optimizer, Optimizer |
| Sanofi-Aventis U.S. LLC | $44.43 | 2019-2024 | |
| Kestra Medical Technology Services, INC. | $39.22 | 2023-2025 | Assure Wcd |
| Bridgebio Pharma, INC. | $23.16 | 2025 | Attruby |
| Baxter Healthcare | $18.12 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Edwards Lifesciences Corporation | $17.63 | 2024 | Sapien 3 Ultra Resilia |
| Chiesi USA, INC. | $15.47 | 2019 | |
| Philips North America LLC | $11.73 | 2020 | |
| Bardy Diagnostics, INC. | $4.00 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Pasi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.